Dr Elizabeth Connolly is a Sarcoma-specialised Medical Oncologist at Peter MacCallum Cancer Centre and an Oncology Research Fellow at ProCan, Children’s Medical Research Institute. She is also an ANZSA Sarcoma Clinical Research Fellow with a Clinical Senior Lecturer appointment at the University of Sydney. Her clinical and research focus is on improving outcomes for sarcoma patients through translational research, multidisciplinary care, and education.
Dr Connolly completed a dedicated sarcoma clinical-research fellowship at Chris O’Brien Lifehouse (2020–2021) and a translational sarcoma PhD at the Children’s Medical Research Institute (2021–2025), applying mass spectrometry-based proteomics to rare sarcoma tissue samples. She has established national and international collaborations with institutions including WEHI, the Garvan Institute, Hudson Institute, and MD Anderson Cancer Center, contributing to multi-centre translational studies and guideline development for ultra-rare sarcomas.
Her research achievements include over 27 peer-reviewed manuscripts since 2020, leadership of international multidisciplinary working groups on genetic predisposition in sarcoma, and multiple clinical and translational projects funded through the ANZSA Sarcoma Research Fellowship. Dr Connolly is also active in oncology education, contributing to ESMO, MOGA, and RACP programs, and co-leading the ESMO International Virtual Mentorship Programme.
Dr Connolly’s work emphasizes collaborative research, evidence-based clinical practice, patient advocacy, and training the next generation of clinicians and researchers, aligning closely with the VCCC Alliance’s mission to integrate research, education, and patient care to improve outcomes in sarcoma.
